Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.78M | 6.49M | 13.29M | 6.22M | 4.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.25M | 15.73M | 19.32M | 11.76M | 8.38M |
| Operating Income | -19.25M | -15.73M | -19.32M | -11.76M | -8.38M |
| Income Before Tax | -17.44M | -13.63M | -20.70M | -10.33M | -7.75M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.44M | -13.63M | -20.70M | -10.33M | -7.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.44M | -13.63M | -20.70M | -10.33M | -7.75M |
| EBIT | -19.25M | -15.73M | -19.32M | -11.76M | -8.38M |
| EBITDA | -19.25M | -15.73M | -19.32M | -11.76M | -- |
| EPS Basic | -0.19 | -0.10 | -0.26 | -0.17 | -0.02 |
| Normalized Basic EPS | -0.12 | -0.09 | -0.15 | -0.09 | -0.10 |
| EPS Diluted | -0.19 | -0.10 | -0.26 | -0.17 | -0.02 |
| Normalized Diluted EPS | -0.12 | -0.09 | -0.15 | -0.09 | -0.10 |
| Average Basic Shares Outstanding | 92.96M | 90.95M | 87.34M | 74.95M | 46.91M |
| Average Diluted Shares Outstanding | 92.96M | 90.95M | 87.34M | 74.95M | 46.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |